As also discussed in previous section, another recent study demonstrated novel roles of CaV3.2 in glioblastoma stem-like cells and further supported the use of mibefradil in combination with temozolomide for glioblastoma therapy [49]. The gene discussed is CACNA1H; the disease is glioblastoma.